| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0006-291X(74)90219-8 |
| P698 | PubMed publication ID | 4608231 |
| P2093 | author name string | M Fujino | |
| T Fukuda | |||
| S Kobayashi | |||
| I Yamazaki | |||
| S Shinagawa | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 406-413 | |
| P577 | publication date | 1974-09-01 | |
| P1433 | published in | Biochemical and Biophysical Research Communications | Q864228 |
| P1476 | title | Synthetic analogs of luteinizing hormone releasing hormone (LH-RH) substituted in position 6 and 10. | |
| P478 | volume | 60 |
| Q39309553 | 4 The Hypophysiotrophic Hormones |
| Q37584359 | A convenient approach to synthesizing peptide C-terminal N-alkyl amides |
| Q40691847 | A novel synthesis of 7-aryl-8-fluoro-pyrrolo[1,2-a]pyrimid-4-ones as potent, stable GnRH receptor antagonists |
| Q92807346 | A phase 3, open-label, multicenter study of a 6-month pre-mixed depot formulation of leuprolide mesylate in advanced prostate cancer patients |
| Q48465649 | Analogs of luteinizing hormone releasing factor (LRF) synthesis and biological activity of [(Nα-Me)Leu7]LRF and [D-Ala6,(Nα-Me)Leu7]LRF |
| Q48374167 | Antagonistic activity of analogs of luteinizing hormone-releasing hormone (LH-RH) in vitro |
| Q39620695 | Aspects of hypothalamic regulation of the pituitary gland |
| Q37602423 | Basic and clinical aspects of GnRH-agonists in reproduction |
| Q44113610 | Bioavailability of leuprolide acetate following nasal and inhalation delivery to rats and healthy humans |
| Q34135364 | Clinical pharmacokinetics of depot leuprorelin |
| Q40828269 | Comparative Ovulation-Inducing Capacity of a Synthetic Luteinizing Hormone-Releasing Hormone and Two Analogs in Adult Rats and Mice |
| Q38803264 | Current status of primary pharmacotherapy and future perspectives toward upfront therapy for metastatic hormone-sensitive prostate cancer. |
| Q67485798 | Delay of puberty and inhibition of reproductive processes in the rat by a gonadotropin-releasing hormone agonist analog |
| Q39267156 | Discovery of LHRH and development of LHRH analogs for prostate cancer treatment |
| Q44991215 | Does a gonadotropin-releasing hormone analogue prevent cisplatin-induced spermatogenic impairment? An experimental study in the mouse |
| Q41338345 | Effects of a gonadotropin-releasing hormone (GnRH) analogue (A-43818) on7,12-dimethylbenz(a)anthracene-induced rat mammary tumors. Histological and endocrine studies |
| Q35049078 | Growth hormone secretagogues: discovery of small orally active molecules by peptidomimetic strategies. |
| Q44911135 | Inhibitory activity of analogues of luteinizing hormone-releasing hormone (LH-RH) in vitro and in vivo |
| Q66901244 | Inhibitory activity of four analogs of luteinizing hormone-releasing hormone in vivo |
| Q43868998 | Initial structure-activity relationship studies of a novel series of pyrrolo[1,2-a]pyrimid-7-ones as GnRH receptor antagonists |
| Q40083840 | LH-RH Agonists and Antagonists |
| Q84622973 | Leuprolide acetate, a GnRH agonist, improves experimental autoimmune encephalomyelitis: a possible therapy for multiple sclerosis |
| Q36823588 | Leuprorelin depot injection: patient considerations in the management of prostatic cancer |
| Q39470213 | Luteinizing hormone-releasing hormone and its analogues: a review of biological properties and clinical uses |
| Q33635297 | Multicenter clinical trial of leuprolide acetate depot (Luphere depot 3.75 mg) for efficacy and safety in girls with central precocious puberty |
| Q64987877 | Novel Thienopyrimidine Derivative, RP-010, Induces β-Catenin Fragmentation and Is Efficacious against Prostate Cancer Cells. |
| Q73850243 | One- and three-month release injectable microspheres of the LH-RH superagonist leuprorelin acetate |
| Q38559686 | Protective effect of leuprolide acetate on 7,12-dimethylbenz(a)anthracene (DMBA)-induced mammary carcinogenesis in rats |
| Q43844876 | Pulmonary peptide delivery: effect of taste-masking excipients on leuprolide suspension metered-dose inhalers |
| Q37230483 | Six-month depot formulation of leuprorelin acetate in the treatment of prostate cancer |
| Q35161023 | Six-month gonadotropin releasing hormone (GnRH) agonist depots provide efficacy, safety, convenience, and comfort |
| Q39684278 | Stimulatory and inhibitory analogs of luteinizing hormone releasing hormone (LHRH). |
| Q41098384 | Structural Biochemistry XIII: Synthesis of Luteinizing Hormone - Releasing Hormone Modification [ Trp8]- LH - RH |
| Q40669143 | Suppression of gonadotropin release and ovulation in animals by inhibitory analogs of luteinizing hormone-releasing hormone |
| Q44071200 | Synthesis and initial structure-activity relationships of a novel series of imidazolo[1,2-a]pyrimid-5-ones as potent GnRH receptor antagonists |
| Q44570479 | Synthesis and structure-activity relationships of 1-arylmethyl-3-(2-aminopropyl)-5-aryl-6-methyluracils as potent GnRH receptor antagonists |
| Q44593722 | Synthesis and structure–Activity relationships of thieno[2,3- d ]pyrimidine-2,4-dione derivatives as potent GnRH receptor antagonists |
Search more.